Towards a deeper understanding of the vaginal microbiota.

Michael France, Madeline Alizadeh, Sarah Brown, Bing Ma, Jacques Ravel

Journal: Nature microbiology 2022;7(3):367-378

PMID: 35246662

Free Full Text on PubMed Central View on PubMed

Plain Language Summary

The vaginal microbiota of reproductive-age cisgender women is often dominated by a single species of Lactobacillus and this is associated with good vaginal health. This review looks at the current understanding of the vaginal microbiota and its connection with host health. Women with vaginal microbiota that are not dominated by Lactobacillus species are often diagnosed with bacterial vaginosis (BV). They have an increased risk for sexually transmitted infections (STI), spontaneous preterm birth, prevalence of human papillomavirus (HPV), increased risk for cervical cancer, urinary tract infections and pelvic inflammatory disease. Factors that affect the vaginal microbiota composition are race, age, pre puberty and menopause where levels of circulating oestrogen are lower. Efforts to modulate the vaginal microbiota with antibiotics, oestrogen therapy, lactic or boric acid and vaginal probiotics have not been that successful. Vaginal microbiota transplants (VMT) are a potential approach to treat recurrent BV but further studies are needed.

Abstract

The human vaginal microbiota is a critical determinant of vaginal health. These communities live in close association with the vaginal epithelium and rely on host tissues for resources. Although often dominated by lactobacilli, the vaginal microbiota is also frequently composed of a collection of facultative and obligate anaerobes. The prevalence of these communities with a paucity of Lactobacillus species varies among women, and epidemiological studies have associated them with an increased risk of adverse health outcomes. The mechanisms that drive these associations have yet to be described in detail, with few studies establishing causative relationships. Here, we review our current understanding of the vaginal microbiota and its connection with host health. We centre our discussion around the biology of the vaginal microbiota when Lactobacillus species are dominant versus when they are not, including host factors that are implicated in shaping these microbial communities and the resulting adverse health outcomes. We discuss current approaches to modulate the vaginal microbiota, including probiotics and vaginal microbiome transplants, and argue that new model systems of the cervicovaginal environment that incorporate the vaginal microbiota are needed to progress from association to mechanism and this will prove invaluable for future research.

Address: Institute for Genome Sciences, University of Maryland, School of Medicine, Baltimore, MD, USA.; Department of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, MD, USA.; Department of Epidemiology and Public Health, University of Maryland, School of Medicine, Baltimore, MD, USA.; Institute for Genome Sciences, University of Maryland, School of Medicine, Baltimore, MD, USA. [email protected].; Department of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, MD, USA. [email protected].

DOI: 10.1038/s41564-022-01083-2